Royal Bank of Canada’s Plus Therapeutics PSTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56
Closed -$1K 7566
2025
Q4
$1K Buy
+56
New +$844 ﹤0.01% 7034
2023
Q2
Hold
0
7567
2023
Q1
Hold
0
7387
2022
Q4
Hold
0
7609
2022
Q3
Hold
0
7765
2022
Q2
Hold
0
7642
2022
Q1
Hold
0
7951
2021
Q4
Hold
0
7839
2020
Q3
Hold
0
6867
2020
Q2
Hold
0
6847
2020
Q1
Hold
0
6950
2019
Q4
Hold
0
7060
2019
Q3
Hold
0
7024
2019
Q2
Hold
0
7112
2019
Q1
Hold
0
7031
2018
Q4
Hold
0
7036
2018
Q3
Hold
0
6902
2018
Q2
Hold
0
6379
2018
Q1
Hold
0
6221
2017
Q4
Hold
0
6409
2017
Q3
Hold
0
6632
2017
Q2
Hold
0
5405
2017
Q1
Hold
0
5262
2016
Q4
Hold
0
5917
2016
Q3
Hold
0
5416
2016
Q2
Hold
0
5495
2016
Q1
Hold
0
5449
2015
Q4
Hold
0
5658
2015
Q3
Hold
0
5290
2015
Q2
Hold
0
5089
2015
Q1
Hold
0
4438
2014
Q4
Hold
0
4984
2014
Q3
Hold
0
4666
2014
Q2
Hold
0
3746
2014
Q1
Hold
0
3531
2013
Q4
Hold
0
3976
2013
Q3
Hold
0
3938
2013
Q2
Hold
0
3807

Other funds holding PSTV

Royal Bank of Canada's PSTV Position: Q1 2026 in Review

Royal Bank of Canada sold out of Plus Therapeutics (PSTV) in Q1 2026, closing a stake of 56 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in PSTV in Q4 2025 and held it in 1 quarter. The position peaked at $1K in Q4 2025. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

  • Royal Bank of Canada reported no remaining Plus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 56 Plus Therapeutics shares in Q1 2026, an estimated $1K.
  • Royal Bank of Canada first reported a position in Plus Therapeutics in Q4 2025 and held it in 1 quarter.
  • Royal Bank of Canada's Plus Therapeutics position peaked at $1K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.